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Only relatively recently has it become clear that mammalian genomes encode tens of thousands of long non-
coding RNAs (lncRNAs). A striking 40%of these are expressed specifically in the brain, where they show pre-
cisely regulated temporal and spatial expression patterns. This begs the question, what is the functional role
of these many lncRNA transcripts in the brain? Here we canvass a growing number of mechanistic studies
that have elucidated central roles for lncRNAs in the regulation of nervous system development and function.
We also survey studies indicating that neurological and psychiatric disorders may ensue when these mech-
anisms break down. Finally, we synthesize these insights with evidence from comparative genomics to argue
that lncRNAs may have played important roles in brain evolution, by virtue of their abundant sequence inno-
vation in mammals and plausible mechanistic connections to the adaptive processes that occurred recently
in the primate and human lineages.Advances in genome sequencing technologies during the last
decade have enabled an unprecedented scale of transcript dis-
covery. One of the key results has been the finding that non-
protein-coding transcripts dominate the transcriptional output
of mammalian genomes (Birney et al., 2007; Carninci et al.,
2005). It is now generally appreciated that at least 80%of the hu-
man genome is dynamically transcribed across the developing
and adult body (Dunham et al., 2012), to produce a wide range
of small non-coding RNAs (sncRNAs; <200 bp) and long non-
coding RNAs (lncRNAs; >200 bp). Functional studies have eluci-
dated a diversity of microRNA (miRNA)-mediated mechanisms
that influence almost every aspect of metazoan biology (re-
viewed in Bushati and Cohen, 2007; Esteller, 2011). More
recently, lncRNAs have begun to receive similar attention from
experimental biologists, resulting in the discovery of a variety
of lncRNA regulatory mechanisms with similarly pervasive influ-
ence. Here we survey these discoveries as they pertain to the
development, plasticity, disease, and evolution of the mamma-
lian brain. We emphasize the abundant opportunities for discov-
ery represented by thewealth of as-yet-uncharacterized nervous
system lncRNAs. First, we introduce key results describing the
spatiotemporal expression dynamics of lncRNAs in the brain,
and the evolutionary conservation of their gene loci.
LncRNAs Are Abundant and Have Precisely Regulated
Expression Patterns in Mammalian Nervous Systems
The GENCODE (Harrow et al., 2012) and NONCODE (Xie et al.,
2014) consortia have annotated 10,000–50,000 lncRNA genes
in the human genome to date. Many are located in regions histor-ically termed gene deserts, between protein-coding genes, while
others overlap protein-coding genes in both antisense and sense
orientations. They range from small single-exon loci to largemulti-
exonic transcripts with several alternative splice forms. Remark-
ably, 40% (equivalent to 4,000–20,000 lncRNA genes) of these
are expressed specifically in the brain (Derrien et al., 2012). This
number is strikingly large given the human genome contains
approximately 20,000–25,000 protein-coding genes in total (Har-
row et al., 2012) and around 2,500 miRNAs (Kozomara and Grif-
fiths-Jones, 2014), with only a subset of these that are specific
to the nervous system. It begs the question, what is the functional
role (if any) of these many lncRNA transcripts in the brain?
Arguing that widespread functional roles may exist for nervous
system lncRNAs, their expression is dynamically regulated during
development (Aprea et al., 2013; Belgard et al., 2011; Lin et al.,
2011; Mercer et al., 2010; Wu et al., 2010) and in response to
neuronal activity (Barry et al., 2014; Kim et al., 2010b; Lipovich
et al., 2012). It also is often highly restricted to specific brain re-
gions in adultmice, suchas thehippocampusorparticular cortical
domains (Mercer et al., 2008). In fact, it was recently shown that
lncRNAs provide more information about cell type identity during
mammaliancortical development thanprotein-codinggenes (Mo-
lyneaux et al., 2015). Thesedynamics and region-specific expres-
sion patterns are coordinated by cell-type-specific or activity-
dependent transcription factors and canonical changes in chro-
matin state at lncRNA loci (Kim et al., 2010b; Ramos et al., 2013).
While some lncRNAs, such as enhancer RNAs or antisense
RNAs (see Box 1 for discussion of lncRNA classes), may have tis-
sue-specific expression as an indirect consequence of someNeuron 88, December 2, 2015 ª2015 Elsevier Inc. 861
Box 1. Regulatory Mechanisms of lncRNAs
Since characterization of the first lncRNAs in 1990 (H19, involved in stem cell differentiation [Brannan et al., 1990; Gabory et al.,
2010]) and 1991 (Xist, essential for X chromosome inactivation [Brown et al., 1991; Pontier and Gribnau, 2011]), the field has made
remarkable progress in determining the mechanisms through which lncRNAs act. Here we summarize some of the key concepts
emerging from this fast-moving field to serve as a framework for understanding lncRNA-mediated control of nervous system
processes.
MODULAR SCAFFOLDS TO CONTROL PROTEIN COMPLEX FORMATION AND LOCALIZATION
LncRNA transcripts often contain multiple modular functional domains, each with specific affinities for particular RNAs, DNA loci,
or protein species (Engreitz et al., 2014; Guttman and Rinn, 2012; Quinn et al., 2014; Tsai et al., 2010). Both sequence-specific and
structural features can specify lncRNA interaction partners (He et al., 2011; Johnsson et al., 2014; Rouskin et al., 2014; Smith et al.,
2013; Wan et al., 2014). The combination of proteins assembled by a particular lncRNA often determines that transcript’s function.
Within the nucleus, lncRNA scaffolds influence the genome-wide binding sites and activity of complexes including: PRC1 (Bonasio
et al., 2014; Yap et al., 2010); PRC2 (Rinn et al., 2007); DNMT1 (Di Ruscio et al., 2013); the mediator complex; transcription factors
such as CBP, NPAS4, CREB, and SRF; and RNA polymerase II (Kaikkonen et al., 2013; Kim et al., 2010b; Lai et al., 2013; Lam et al.,
2013; Li et al., 2013; Melo et al., 2013; Mousavi et al., 2013; also see Batista and Chang, 2013b for other examples). Cytoplasmic
lncRNA scaffolds have been demonstrated to influence gene expression by controlling the stability (Kretz et al., 2013), degradation
(Gong and Maquat, 2011), translational activation (Carrieri et al., 2012), and translational repression (Yoon et al., 2012) of mRNAs
containing specific recognition motifs, by assembling appropriate protein machineries on target transcripts.
SEQUESTERING PROTEIN AND RNA (DECOYS)
LncRNAs can influence gene regulation by acting as decoys, which inactivate transcription factors or miRNAs by binding to them
and diverting them from their normal sites of action (Hung et al., 2011; Johnsson et al., 2013; Sun et al., 2013; Wang et al., 2013;
Willingham et al., 2005). The lncRNA NEAT1 delays translation of specific mRNAs by sequestering them within nuclear para-
speckles and releasing them for translation upon NEAT1 downregulation (Chen and Carmichael, 2009). Large intergenic spacer
(IGS) ncRNAs are transcribed from rDNA repeats and sequester proteins with specific signal motifs within the nucleolus (Audas
et al., 2012).
INTRINSIC CATALYTIC FUNCTIONS (SIGNALS)
Transcripts such as the CCND1 lncRNAs allosterically modify specific protein targets to activate or deactivate their natural func-
tions via intrinsic catalytic activities (Wang et al., 2008). This mechanism is distinct to scaffolding and decoy functions.
CIS- VERSUS TRANS-ACTING DISTINCTION
A cis-regulatory mechanism affects genes that are proximal to a given lncRNAs locus. For example, many protein-coding genes
have partially overlapping antisense lncRNAs that regulate their expression (Katayama et al., 2005; Modarresi et al., 2012; Yu et al.,
2008), by direct transcriptional interference (Martens et al., 2004) or by recruiting epigenetic machineries such as PRC2 (Kaneko
et al., 2013) or SET2 and SET3 (van Werven et al., 2012) as nascent transcripts. In contrast, trans-acting lncRNAs bind to and
impact the expression of target genes throughout the genome, which are often distant to the lncRNA locus (Chu et al., 2011; Johns-
son et al., 2013; Vance et al., 2014).
THE LNCRNAS AND TOPOLOGICAL ORGANIZATION OF THE NUCLEUS
The boundaries between cis- and trans-actingmechanisms are being blurred by new studies that emphasize the interplay between
three-dimensional chromatin organization and RNA function. For example, the lncRNA XIST searches for genomic binding sites by
spatial proximity (Engreitz et al., 2013). The lncRNA FIRRE is expressed from the X chromosome and drives co-localization of five
trans-chromosomal contacts at its site of transcription to control adipogenesis-associated gene expression patterns (Hacisuley-
man et al., 2014). Such mechanisms are not easily classified as cis- or trans-acting by conventional definitions. Super-resolution
imaging of lncRNA and protein localization in live cells also is beginning to provide insights into the dynamic features governing
lncRNA function within the nucleus (Cerase et al., 2014), further blurring cis- versus trans-acting distinctions. Some further discus-
sion of principles relevant to this emerging mechanistic paradigm can be found in Batista and Chang (2013a, 2013b).
(Continued on next page)
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RNA CONFORMATIONAL DYNAMICS
RNA molecules can generally access multiple low free-energy conformations, each of which may have different functional prop-
erties depending on the particular structural domains and free sequencemotifs associated with it (reviewed in Dethoff et al., 2012).
RNA molecules exist within a cell as a distribution of these energetically favorable conformations in numbers proportional to the
relative sizes of each accessible local energyminima. Emerging evidence indicates that cells can directly influence this distribution
by altering RNA free-energy landscapes downstream of familiar signaling mechanisms. The final effectors driving such changes
can be RNA-binding proteins, chaperones, helicases, small molecules, metabolites, or various ions. This theoretically allows
the functional repertoire of a given RNA molecule to be modified reliably in space and time, dramatically increasing functional
complexity of RNA-mediated cellular mechanisms per RNAmolecule, with significant implications for cellular information process-
ing (reviewed in Dethoff et al., 2012). An exciting area of future research might try and connect ionic strength changes during
neuronal depolarization to switch-like functions of synaptic lncRNAs.
Box 1. Continued
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(lincRNAs, >7,000 in the human genome) have their own inde-
pendently regulated promoters that undergo canonical tran-
scription factor binding and chromatin remodeling events inde-
pendent of any other known functions performed at that locus
(Cabili et al., 2011; Guttman et al., 2009; Ramos et al., 2013).
Obviously, regulated expression does not prove a functional
role for lncRNAs, but it is consistent with it. The evidence for
lncRNA functionality in the nervous system is developed below
as the main subject of this review.
Evolutionary Conservation of lncRNA Loci
If functional, we might naturally expect lncRNA loci to show
evidence of sequence conservation. Indeed, lncRNAs possess
highly conserved promoters whose transcription factor-binding
sites correlate with their tissue-specific expression patterns
(Derrien et al., 2012; Guttman et al., 2009). They also have
highly conserved splice-junction motifs (Nitsche et al., 2015). In
contrast, lncRNA gene bodies show relatively low evolutionary
conservation, similar to that observed in many cis-regulatory se-
quences and ancient retrotransposons that have been main-
tained in the mammalian lineages (which may or may not be
functional). This observation prompted some to argue that
lncRNAs do not have important biological functions, without
much consideration of the circularity of conservation indices
and the likelihood that regulatory sequences not only have
different structure-function constraints but also are the major
sites of adaptive radiation (Pheasant and Mattick, 2007). More-
over, experimental studies have now shown that the function
of specific lncRNAs can be preserved despite this apparent
lack of primary sequence conservation (Pang et al., 2006; Ulitsky
et al., 2011). In fact, several human lncRNAs have been shown to
phenotypically rescue depletion of their homologs in zebrafish
(Ulitsky et al., 2011). Thus, it seems that the low conservation
of lncRNA gene bodies relative to protein-coding genes reflects
lower sequence constraint, rather than a lack of functional
importance, with other studies showing higher conservation of
RNA structure (Smith et al., 2013). Further supporting this view,
several studies have used mutant mouse model systems to un-
derstand the role of lncRNAs in the brain. The results of these
studies, notably thePANTR1,VISC2, andEVF2 lncRNA loci, indi-
cate that a large fraction is required for mammalian life and
development (Sauvageau et al., 2013).Is lncRNA function truly independent of protein-coding poten-
tial? In short, this seems to be the case for the vast majority of
lncRNAs. Comparison of RNA sequencing and mass spectrom-
etry data for at least two cell lines indicates that 92% of anno-
tated lncRNAs produce no detectable peptides (Ba´nfai et al.,
2012; Derrien et al., 2012; also see Gascoigne et al., 2012; Gutt-
man et al., 2013).
Molecular Mechanisms of lncRNAs in Nervous System
Development
Nervous system development is a complex and highly stereo-
typed process that requires precise spatiotemporal regulation
of stem/progenitor cell proliferation and differentiation. These
developing populations of cells also must form appropriate con-
nections with each other if the brain is to function properly. In this
section we introduce emerging mechanistic roles for lncRNAs in
controlling both these processes (summarized in Figure 1).
Stem/Progenitor Cell Proliferation and Differentiation
Developmental cell-fate choices aremade by the sequential acti-
vation of cell-type-specific gene regulatory programs in prolifer-
ating embryonic stem/progenitor cells. LncRNAs control this
process at various stages along the progression from pluripotent
cells, which are found in the early embryo, through to the terminal
cell types found in the mature mammalian brain (Figure 1).
Insights In Vitro
The exit from pluripotency and early neural differentiation has
been studied extensively using in vitro model systems, such as
embryonic stem cells (ESCs). In mouse ESCs, systematic loss-
of-function studies have identified dozens of lncRNAs that are
necessary for establishing pluripotency or driving neural lineage
entry (Guttman et al., 2011; Ng et al., 2012; Sheik Mohamed
et al., 2010). These lncRNAs are often directly regulated by ca-
nonical pluripotency transcription factors, such as OCT4,
SOX2, and NANOG. They in turn exert their regulatory influence
by directing transcription factors or chromatin remodeling ma-
chineries to specific lineage-specifying genes. For example,
the lncRNA RMST is regulated by the transcription factor
REST, which induces its expression during neural differentiation
in vitro.RMST then drives the recruitment of the neural transcrip-
tion factor, SOX2, to key neurogenesis-promoting genes, such
as DLX1, ASCL1, HEY2, and SPS (Ng et al., 2013a; Figure 1).
Loss of RMST blocks exit from the ESC state and initiation of
neural differentiation; it is required for neural differentiation.Neuron 88, December 2, 2015 ª2015 Elsevier Inc. 863
AB
C
D
E
F
G
H
I
J
K
L
Figure 1. Summary of lncRNA Roles in Neuronal Development and Their Associated Complexes
Emerging functional studies demonstrate that lncRNAs play a major role in neuronal development from early neural differentiation (left) to late-stage synapto-
genesis (right).
(A–E) LncRNAs are necessary for early neurogenic commitment, during which they recruit transcriptional machineries to specific neural gene promoters.
(F–H) In dividing neural precursors, lncRNAs also control later cell-fate choices, by similarly scaffolding epigenetic machineries, transcription factors, or splicing
regulators, around specific target-gene loci. Examples shown are interneuron specification (F) and retinal cell development (G and H).
(I–L) Late developmental processes, such as neurite outgrowth and synapse maturation (I), as well as regulated cell death in neural circuit establishment (J), are
regulated by natural antisense lncRNAs. Additionally, lncRNAs regulate synapse function (K) through their ability to recruit splicing factors to relevant transcripts
and through the recruitment of translational repression machineries (L) to specific target mRNAs within local synaptic environments.
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by a similar mechanism. TUNA forms a complex with three
RNA-binding proteins, NCL, PTBP1, and hnRNP-K, that together
localize to neural gene promoters in differentiating mouse
ESCs (Lin et al., 2014). Knockdown of TUNA, or any one of the
three interacting RNA-binding proteins, is sufficient to
inhibit neural differentiation (Lin et al., 2014). Amazingly, experi-
ments in zebrafish showed that this functional role was
conserved across relatively distantly related vertebrates, mice
and zebrafish, reinforcing the deep evolutionary requirement
for lncRNA-driven neural lineage commitment.
TUNA and RMST exemplify how lncRNAs can control cell-fate
choices by directing transcription factors and chromatin-remod-
eling machineries to important target loci. There are other exam-
ples. The lncRNA DALI drives the expression of an essential
neuronal differentiation gene expression program in neuroblas-
toma cells. Genomic target mapping by Capture Hybridization
Analysis of RNA Targets (CHART) revealed that this function is
mediated through direct interactions with the transcription factor
POU3F, the DNA methyltransferase DNMT1, and thousands of
target loci across the genome (Chalei et al., 2014). Similarly,
the lncRNA PAUPAR interacts with the PAX6 transcription factor
and localizes to specific promoter loci, including SOX2,NANOG,
and HES1, to regulate a transcriptional program that influences
the cell-cycle profile and differentiation of neuroblastoma cells
(Vance et al., 2014).
The lncRNA-driven transcription factor localization exempli-
fied by TUNA, RMST, DALI, and PAUPAR represents an attrac-
tive mechanism for regulation of cell-fate choice, because it can
allow complex gene expression programs to be controlled by a
single lncRNA. It has been suggested that a large fraction of864 Neuron 88, December 2, 2015 ª2015 Elsevier Inc.lncRNAs (i.e., hundreds to thousands of other lncRNA genes)
also operate this way during differentiation. This is based largely
on the observation that more than 30%of lncRNAs inmouse and
human ESCs physically interact with particular chromatin-modi-
fying complexes, and they have correlated expression with their
targets (Guttman et al., 2011; Khalil et al., 2009; also see Box 1).
Although attractive and plausible, the high risk of non-specific in-
teractions between nuclear proteins and large RNA molecules
necessitates careful validation to eliminate the possibility of indi-
rect or protein-independent effects misleadingly creating the de-
tected expression correlations. Work in this space is maturing,
and will ultimately clarify the biophysical rules that specify which
proteins and genomic loci are bound by a given lncRNA.
Examples In Vivo
Regulation of cell-fate choice by lncRNAs has been studied
in vivo; it has been shown that lncRNAs control stem cell turn-
over and the specification of particular lineages in the embryonic
mouse brain. EVF2was the first nervous system-specific lncRNA
to undergo detailed mechanistic characterization in vivo (Bond
et al., 2009). It was shown that genetic deletion of EVF2 in
mice disrupts the excitatory to inhibitory neuron balance in the
postnatal hippocampus and dentate gyrus. This imbalance
was characterized by reduced synaptic inhibition, caused by
the failure of GABAergic interneuron specification (Bond et al.,
2009). Mechanistically, EVF2 recruits the transcription factor
DLX and methyl-CpG-binding protein MECP2 to regulatory re-
gions controlling the expression of interneuron lineage genes,
including as DLX5, DLX6, and GAD1, by both cis- and trans-
acting scaffolding mechanisms (Bond et al., 2009). EVF2 has
also been implicated in controlling the methylation state of the
DLX5/6ei enhancer control region, which regulates expression
Neuron
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(Berghoff et al., 2013). How this methylation control by EVF2 is
integrated with its recruitment activities of DLX and MECP2 is
unknown. Nonetheless, EVF2 is a clear example of the develop-
mental significance of lncRNA regulatory mechanisms in vivo.
The lncRNA PNKY is expressed in the nucleus of dividing neu-
ral stem cells (NSCs) in the developing mouse and human brain,
where it acts as a regulator of NSC turnover (Ramos et al., 2015).
Depletion of PNKY leads to loss of the NSC phenotype in ventric-
ular zone cells and expansion of the transit-amplifying neuronal
progenitor pool in postnatal mouse brains. Thus, PNKY controls
the balance between self-renewal and neuronal differentiation in
dividing NSCs. PNKY appears to execute this function through
regulation of an important alternative splicing pathway that
involves an interaction with splicing regulator PTBP1 (Ramos
et al., 2015), though precise epistatic relationships in this
pathway remain to be resolved.
The intergenic lncRNA linc-BRN1B controls differentiation of
delaminating neural progenitor cells in vivo. Deletion of the
linc-BRN1B (Pantr2) locus results in significant loss of upper
cortical layers (II/III–IV), as well as a reduction in barrel number
and size within the somatosensory cortex and posteriomedial
barrel subfield of developing mouse pups. These reductions
originate with loss of basal cortical progenitors, which subse-
quently drives precocious migration and differentiation of lower
layer neurons (Sauvageau et al., 2013). Linc-BRN1B appears
to regulate the levels of its neighboring BRN1 protein, which
may be important for its ability to regulate basal cortical progen-
itor turnover. Together these studies on EVF2, PNKY, and linc-
BRN1B establish the in vivo relevance of lncRNAs in the regula-
tion of nervous system development.
Several other lncRNAs have been associated with cell-fate
choice in vivo, in the developing retina, though their precise
mechanisms of action are currently less clear. In fact, some of
the first lncRNAs to be implicated in the control of cell-fate
choice in the nervous system were identified by early studies in
the retina (Alfano et al., 2005; Blackshaw et al., 2004; Young
et al., 2005). TUG1, a nuclear restricted lncRNA, and VAX2OS1
have been implicated in the control of retinal cell-type specifica-
tion and proliferation (Meola et al., 2012; Yang et al., 2011; Young
et al., 2005). SIX3OS controls the specification of photorecep-
tors, bipolar cells, and Muller glia, possibly through regulation
of SIX3 target genes via a mechanism that involves interactions
with EZH2 and EYA proteins (Rapicavoli et al., 2011). GOMAFU
is expressed in the nucleus of dividing NSCs and differentiating
neurons. It regulates splicing of several neuronal genes,
including DISC1, ERRB4, and WNT7B, likely through interac-
tions with splicing proteins SF1, SRSF1, and QKI (Barry et al.,
2014; Sone et al., 2007; Tsuiji et al., 2011). Depletion of GOMAFU
in embryonic mice leads to increased amacrine cell and Muller
glia differentiation (Rapicavoli et al., 2010), as well as an improp-
erly regulated transition of actively dividing ventricular zone pro-
genitor cells into differentiating neurons as they migrate outward
into the cortical plate (Aprea et al., 2013).
Overall, lncRNAs regulate cell-fate choice and stem/progeni-
tor cell turnover during neural development in vitro and in vivo.
To do this they execute lineage-specific gene expression pro-
grams by organizing epigenetic, transcriptional, or post-tran-scriptional protein machineries in space and time, in response
to differentiation signals (Figure 1; also see Box 1).
Neurite Elaboration and Synaptogenesis
As the nervous system develops, an intricate process of neu-
rite elaboration unfolds, such that populations of neurons
faithfully establish the connections required for normal brain
function. This is an enormous regulatory task. Examples of
how lncRNAs contribute are beginning to emerge and are
introduced here.
The first example of a lncRNA that regulates synaptogenesis
is BC1/BC200, which was one of the earliest studied lncRNAs
in any tissue. BC1/BC200 is expressed in the developing and
adult nervous system where it is actively trafficked to dendrites
(Muslimov et al., 1997). There it interacts with FMRP and trans-
lational machineries, including eIF4a and poly(A)-binding pro-
tein (PABP), to control 48S complex formation and repress
local translation in synapses (Wang et al., 2002; Zalfa et al.,
2003). Through this mechanism, BC1/BC200 regulates spatially
restricted synaptic turnover in vivo (Lewejohann et al., 2004;
Skryabin et al., 2003; Zhong et al., 2009). Some of the physio-
logical consequences of this regulation are known; we refer the
interested reader to the neural plasticity section below for
further discussion.
More recently, it was found that antisense lncRNAs regulate
several important proteins that control neurite elaboration,
including BDNF, GDNF, and EPHB2 (Modarresi et al., 2012). In-
hibition of the lncRNA BDNF-AS, which is transcribed antisense
to the BDNF growth factor gene, resulted in a 2- to 7-fold in-
crease in BDNF protein levels, which was associated with
reduced EZH2 recruitment and altered chromatin state at the
BDNF locus. The resulting BDNF overexpression then drove
elevated neuronal outgrowth, differentiation, survival, and pro-
liferation, both in vitro and in vivo (Modarresi et al., 2012).
Thus, antisense lncRNAs control developmental neurite elabo-
ration through regulating local gene expression. Another
exciting feature of this work by Modarresi et al. (2012) was their
demonstration that antisense lncRNA expression could be
easily modulated in vivo by antisense oligonucleotides, to spe-
cifically induce expression of their overlapping protein-coding
gene, opening the possibility of lncRNA-targeting therapeutics
that activate gene expression. Antisense lncRNA transcripts
are remarkably pervasive in mammalian genomes (Faghihi
and Wahlestedt, 2009; Katayama et al., 2005). Examples
such as BDNF-AS may thus prelude a form of lncRNA regula-
tion that is of widespread developmental and therapeutic
importance.
MALAT1 is another famous lncRNA implicated in regulation of
neurite elaboration. It is an interesting case study due to conflict-
ing in vitro and in vivo results.MALAT1 is abundantly expressed
in neurons and is enriched in nuclear speckles in a transcription-
dependent manner. In vitro, in cultured hippocampal neurons,
MALAT1 has been shown to actively recruit SR-family splicing
proteins to transcription sites to control the expression of synap-
togenesis-related genes (Bernard et al., 2010). Moreover, knock-
down ofMALAT1 in this system results in a decrease in synaptic
density, while overexpression reciprocally increases synaptic
density (Bernard et al., 2010). Thus,MALAT1 appeared to regu-
late synaptogenesis by modulating synapse formation/Neuron 88, December 2, 2015 ª2015 Elsevier Inc. 865
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domain. However, it subsequently was reported that MALAT1
knockout mice surprisingly showed no overt phenotype, neither
in behavior nor in neuropil density (Zhang et al., 2012a).
There has therefore been significant concern about the corre-
spondence of lncRNA behaviors in vitro to their developmental
role in vivo. It is possible that closer examination of the neurolog-
ical and behavioral phenotypes ofMALAT1 knockout mice could
reveal more subtle phenotypic defects, or that special redun-
dancies in vivo could potentially compensate for the loss of
MALAT1 function. Nonetheless, such results underscore the
importance of completing lncRNA functional analyses with thor-
ough in vivo characterization, although negative results are
inconclusive. Note that most of the lncRNAs discussed in this re-
view have indeed been characterized in vivo and so meet this
more stringent criteria.
Molecular Mechanisms of lncRNAs in Neuronal
Plasticity
Neurons are able to change their set of synaptic connections and
the relative strength of each of these connections over time in
response to sensory experience and other environmental cues.
This so-called plasticity underlies learning, memory, and cogni-
tion, as well as the brain’s ability to recover from injury or insult.
Many molecular pathways that implement plasticity are known
(for reviews see Costa-Mattioli et al., 2009 and West and
Greenberg, 2011). However, these descriptions are still incom-
plete. Here we introduce studies that have begun to implicate
lncRNAs in the control of neuronal plasticity (summarized in
Figure 2). Already two of these lncRNAs, KCN2AS and BC1/
200, have been convincingly tied to concrete behavioral
phenotypes. Many others remain exciting candidates for future
exploration.
Transcriptional Regulation in Response to Injury and
Neuronal Activity
Changes in expression of genes such as ion-channel compo-
nents or signaling proteins can dramatically alter the excitability
and functional properties of a neuron. For example, potassium
channels mediate potassium ion influx during neuronal action
potential propagation. The shape of an action potential and the
sensitivity of a potassium channel to depolarization can be tuned
by modifying the stoichiometry of potassium channel protein
subunits (Stu¨hmer et al., 1989). Thus, the regulation of these
components in response to environmental cues can contribute
to neuronal plasticity.
KCNA2 is a core potassium channel subunit, whose expres-
sion is regulated by an overlapping antisense RNA in response
to peripheral nerve injury and in neuropathic pain (Zhao et al.,
2013). In a healthy rat model system, KCNA2-AS is expressed
only lowly in a subset of 20% of dorsal root ganglion (DRG)
neurons, while KCNA2 is expressed highly inmost DRG neurons.
However, in response to peripheral nerve injury, KCNA2-AS is
strongly induced by the MZF1 zinc-finger transcription factor
across the DRG neuronal population independently of KCNA2.
Elevated KCNA2-AS then selectively downregulates KCNA2
mRNA and protein both in vitro and in vivo. The precise mecha-
nism through which KCNA2-AS downregulates KCNA2 mRNA
and protein awaits future elucidation, though itmay involve direct866 Neuron 88, December 2, 2015 ª2015 Elsevier Inc.binding between sense and antisense transcripts given their sig-
nificant sequence overlap, or alternatively, competition for some
DNA- or RNA-binding factor that ordinarily drives KCNA2
expression. In any case, this regulation alters the functional
properties of DRG neurons in living rats. Specifically, overex-
pression of KCNA2-AS in the DRG was shown to reduce total
voltage-gated potassium current and increase neuronal excit-
ability, producing mechanical and pain hypersensitivities that
are core neuropathic pain symptoms in the clinic. Remarkably,
blocking KCNA2-AS induction attenuated these symptoms
following peripheral nerve injury. KCNA2-AS thus modulates
neuronal plasticity in response to peripheral nerve injury, and it
represents a potential therapeutic target in the treatment of hu-
man neuropathic pain.
There is some evidence that other antisense RNAs also
contribute to the regulation of neuronal plasticity through
controlling signaling molecule expression, but in response to
neuronal activity. BDNF is an important growth factor in the ner-
vous system that controls the decision between synaptic main-
tenance and elimination in response to sustained versus sparse
activity respectively. This regulation underlies the synaptic
consolidation hypothesis (Bramham and Messaoudi, 2005). As
introduced above, it was recently shown that BDNF expression
is regulated by an overlapping antisense RNA, BDNF-AS. Inter-
estingly, BDNF-AS expression is activity dependent (Lipovich
et al., 2012; Modarresi et al., 2012). It may thus play a mecha-
nistic role in coupling neuronal activity to BDNF expression
and synaptic turnover in neuronal plasticity, though this awaits
direct empirical support.
Generally speaking, regulated transcription in response to
neuronal activity is a central process in long-term neuronal plas-
ticity (reviewed in West and Greenberg, 2011). Such activity-
dependent transcription links the transcriptional output and,
thus, protein composition of a neuron to its recent firing history
and is required for canonical Hebbian learning. In a screen for
such activity-dependent transcripts, Kim et al. (2010b) identified
thousands of enhancer-associated lncRNAs (eRNAs) that were
rapidly induced by >2-fold following depolarization of mouse
cortical neurons by potassium chloride in vitro. Though the ma-
jority of these transcripts currently have not been subjected to
careful functional interrogation, their expression changes corre-
late strongly with changes in expression of nearby protein-cod-
ing genes (Kim et al., 2010b). In other biological systems, an
increasing number of mechanistic studies have shown that eR-
NAs are essential for enhancer function. The eRNAs drive recruit-
ment of the mediator complex, transcription factors such as
CBP, NPAS4, CREB, and SRF, and RNA polymerase II, to
enhancer loci, and they are required for their transcription pro-
moting activity at target genes (Kaikkonen et al., 2013; Kim
et al., 2010b; Lai et al., 2013; Lam et al., 2013; Li et al., 2013;
Melo et al., 2013;Mousavi et al., 2013). There is no reason a priori
to suspect that a version of this mechanism does not also occur
in the nervous system. We suggest that mechanistic exploration
of activity-dependent eRNAs in neuronal plasticity is an exciting
topic for future exploration.
Similarly to Kim et al. (2010b), others have shown that hun-
dreds of lncRNAs that are not eRNAs are also dynamically
regulated by neuronal depolarization in vitro (Barry et al., 2014;
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Figure 2. Molecular Mechanisms of lncRNAs in Synaptic Plasticity
LncRNAs respond to neuronal activity or injury and modulate synaptic properties (top) or gene expression (bottom) in neuronal plasticity.
(A) BDNF-AS is the natural antisense transcript to BDNF, itself a key contributor to synaptic function. By dynamically repressing BDNF expression in response to
neuronal depolarization, BDNF-AS modulates synaptic function.
(B)MALAT1 expression level controls spine maturation and synapse formation, both during development and in response to neural activity, by recruiting splicing
factors into a currently poorly understood splicing domain within the nucleus.
(C) BC1/200 expression is modulated by neuronal activity and controls the translational repression of specific target mRNAs within synapses through a
mechanism involving direct recruitment of translational machineries.
(D) Enhancer RNAs are emerging as key activity-dependent regulators of synapse development through their recruitment of multiple proteins required for
neuronal gene expression to transcription start sites.
(E) GOMAFU controls the activity-dependent release of splicing factors from a nuclear domain to regulate gene expression patterns and splice variant distri-
butions that influence behavior in mice.
(F) In the peripheral nervous system, KCNA2-AS is induced in response to nerve injury. It thus dynamically downregulates expression of the KCNA2 potassium
channel subunit, which alters neuronal firing properties. This mechanism is a key driver of neuropathic pain symptoms in rats.
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ReviewLipovich et al., 2012). Among these, GOMAFU andMALAT1 are
potentially interesting examples. Both are abundantly expressed
in neurons and form ribonucleoprotein complexes within the nu-cleus that are enriched in splicing proteins. Though speculative,
such transcripts may couple neuronal activity to specific post-
transcriptional modifications in neuronal plasticity.Neuron 88, December 2, 2015 ª2015 Elsevier Inc. 867
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Translational control of neuronal plasticity plays a key role in
regulating long-term changes in neural circuits underlying
learning, memory, and behavior (reviewed in Costa-Mattioli
et al., 2009).
The BC1/200 lncRNA regulates translation of specific mRNAs
within local synaptic domains in response to neuronal activity.
The mechanism through which BC1/200 controls synaptic trans-
lation was introduced in the developmental neurite elaboration
section above. Briefly, the BC1/200 lncRNA is actively trafficked
to neuronal dendrites where it acts as a scaffold that interacts
with FMRP and translational machineries, including eIF4a and
PABP, to control 48S complex formation and repress local trans-
lation in synapses. Beyond this previous discussion, here we note
thatBC1/200expression is in fact dynamically upregulatedat spe-
cific synapses by local neuronal activity (Muslimov et al., 1998).
Thus, BC1/200 represents a canonical plasticity gene that mod-
ifies the protein composition of synapses in response to neuronal
activity. Increased neuronal activity in a particular dendritic region
would cause higher local expression of BC1/200, which would
then negatively feedback on local translation rates.
Genetic deletion of BC1/BC200 in mice results in uncontrolled
group I metabotropic glutamate receptor-stimulated synaptic
translation, neuronal hyperexcitability, convulsive seizures, anx-
iety, and exploratory behavior defects (Lewejohann et al., 2004;
Skryabin et al., 2003; Zhong et al., 2009). Thus, it is clear that
translational control by BC1/200 is an essential neuronal plas-
ticity mechanism; its breakdown leads to abnormal neuronal ac-
tivity and diverse behavioral defects. This example extends the
known influence of lncRNAs in the nervous system outside of
the nucleus and into the synaptic environment. It is to our knowl-
edge the only example to date of a lncRNA that regulates trans-
lation in neurons.
Implicating lncRNAs in Neural Disease Pathogenesis
Since lncRNAs regulate nervous system development and func-
tion, it makes sense that their dysregulation or mutation would
cause neurological disorders. Indeed, genome-wide association
studies (GWASs) and comparative transcriptomic studies have
associated lncRNAs with conditions including schizophrenia,
Alzheimer’s disease (AD), autism spectrum disorder (ASD), As-
perger’s syndrome, amyotrophic lateral sclerosis (ALS), bipolar
disorder, depression, Parkinson’s disease, neurofibromatosis,
neuropathic pain, attention deficit hyperactivity disorder, epi-
lepsy, brain cancers, and a range of cognitive performance met-
rics (Brunner et al., 2012; Cabili et al., 2011; Han et al., 2012;
Kerin et al., 2012; Pasmant et al., 2011; Syrbe et al., 2015; Talk-
owski et al., 2012; Zhang et al., 2012b; Zhao et al., 2013; Zhou
et al., 2012). Although the majority of this work has provided as-
sociation without yet clearly establishing causation, several ex-
amples of causal lncRNA disease mechanisms are beginning
to emerge. We introduce some of these below. For a broader
coverage we refer the interested reader to two comprehensive
recent reviews on the topic (see Ng et al., 2013b and Qureshi
and Mehler, 2012).
ASD
ASD is a neurodevelopmental condition of complex etiology that
is characterized by social and cognitive impairments and repet-868 Neuron 88, December 2, 2015 ª2015 Elsevier Inc.itive behaviors (De Rubeis and Buxbaum, 2015; McCarroll and
Hyman, 2013; Willsey and State, 2015).
GWASs on ASD have identified strongly disease-associated
variants in the chromosomal region 5p14.1 (Wang et al., 2009).
The lack of protein-coding genes in this region made this asso-
ciation initially difficult to explain. Kerin et al. (2012) later found
that these variants reside near a 4-kb lncRNA that is tran-
scribed antisense to moesin pseudogene 1 (MSNP1AS) and
that shares 94% sequence identity with the 4-kb mature
MSN mRNA. This finding was immediately interesting because
MSN is itself a well-known regulator of synapse development
and function (Furutani et al., 2007; Kim et al., 2010a; Paglini
et al., 1998; Sanchez et al., 2009). Thus, if MSNP1AS locus
variants altered the regulation of MSN protein expression or
function, it could explain how these variants might underlie the
development of synaptic dysfunction in ASD.
Several pieces of evidence support this hypothesis (Kerin
et al., 2012). First, all three SNP genotypes in the MSNP1AS
locus are significantly associated with the expression level
of MSNP1AS. The expression level of MSNP1AS is itself
also positively correlated with expression of MSN mRNA and
protein in the brain, and both MSNP1AS and MSN are over-
expressed in ASD patient brains by >10- and 2-fold, respec-
tively. Second, experiments in vitro indicate that MSNP1AS
can directly bind MSN mRNA through its strong sequence
homology. Finally, overexpression of MSNP1AS directly alters
the expression of MSN protein levels, though these results
were sometimes conflicting between experiments conducted
in different cell lines. Though yet to be carefully validated
in vivo, on the basis of these results, Kerin et al. (2012) sug-
gested that MSNP1AS may regulate MSN protein by binding to
and stabilizing MSN mRNA, and that this mechanism may
causally connect SNP variants in the MSNP1AS locus to ASD
pathogenesis.
Schizophrenia
Schizophrenia is a psychiatric disorder associated with behav-
ioral abnormalities, cognitive and emotional impairment, and
psychosis. It commonly manifests between the ages of 10 and
40, has high heritability (estimated at80% in twin studies), hun-
dreds of associated risk loci, strong environmental risk factors,
and affects 1% of the population (Ro¨ssler et al., 2005; Sullivan
et al., 2003; SWGPGC, 2014).
No unique set of abnormalities is currently sufficient for the
diagnosis of schizophrenia. Instead, it has been speculated
that diverse molecular processes converge in various combina-
tions in the pathophysiology of disease (Harrison and Wein-
berger, 2005). Though this pathogenic process is complex,
several molecular signatures stand out. In particular, changes
in the splice-isoform distributions of ERRB4, an adhesion mole-
cule and receptor tyrosine kinase (Law et al., 2007), andDISC1, a
functionally pleiotropic and broadly interacting intracellular
molecule (Brandon and Sawa, 2011; Nakata et al., 2009), occur
frequently and are thought to directly contribute to pathogenic
neural development and function in schizophrenia (James
et al., 2004; Veikkolainen et al., 2011). In some cases, direct mu-
tation ofDISC1 or ERRB4 is thought to underlie their pathological
splicing, but for many other patients the root cause of splicing
defects is unknown.
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may be involved in driving this aberrant splicing of DISC1 and
ERRB4 in schizophrenia (Barry et al., 2014).GOMAFU is an inter-
esting candidate gene because multiple independent studies
previously have associated its mutation or dysregulated expres-
sion with schizophrenia risk (Albertson et al., 2006; Barry et al.,
2014; Di Chiara et al., 2004; Michelhaugh et al., 2011; Spadaro
et al., 2015; Takahashi et al., 2003). It also forms a ribonucleopro-
tein complex in the nucleus that is enriched in three splicing pro-
teins, SRSF1, SF-1, and QKI, providing a plausible mechanism
that could be dysregulated to generate schizophrenia splicing
phenotypes (Barry et al., 2014). In healthy mice, GOMAFU
controls cell-fate choices in the developing retina, and it is also
highly expressed in the CA1 region of the hippocampus and in
large excitatory projection neurons of the cortex (Sone et al.,
2007). There it is dynamically regulated by neuronal activity
(Barry et al., 2014). However, in contrast to these natural and
reversible expression level changes, we found that chronic
downregulation of GOMAFU in human pluripotent-cell-derived
neurons in vitro in fact drives splicing defects in DISC1 and
ERRB4 (Barry et al., 2014). Moreover, these defects exactly
quantitatively mimic those seen in schizophrenia patient cortex
samples and correspond coherently with the lower GOMAFU
expression seen in schizophrenia patient brains (Barry et al.,
2014). This situation would mirror loss-of-function mutations in
the GOMAFU locus, suggesting a lncRNA-driven mode of
splicing-defect pathogenesis in schizophrenia.
AD
AD is a heritable neurodegenerative disorder that currently af-
fects >1% of the living global population (Brookmeyer et al.,
2007; Gatz et al., 2006; also see Karch et al., 2014 for a recent
review). AD generally manifests in the elderly and is associated
with progressively worsening dementia and memory loss,
which eventually leads to the death of patients at an average
of 7 years post-diagnosis (Brookmeyer et al., 1998; Mo¨lsa¨
et al., 1986). A core molecular pathway driving progressive neu-
rodegeneration in AD is thought to be the so-called amyloid
cascade, in which toxic amyloid peptides accumulate and
cause neuronal atrophy (see Musiek and Holtzman, 2015 for
a recent review).
The lncRNABACE1-AS has been implicated in a positive feed-
back loop that drives progression of this amyloid cascade
(Faghihi et al., 2008). BACE1-AS is transcribed antisense to
and overlapping the BACE1 gene, which encodes a trans-mem-
brane beta-secretase protein, whose dysregulation is well
known to drive overproduction of pathogenic AB-42 peptides
in AD. Functionally, BACE1-AS positively regulates BACE1
in vitro and in vivo by binding to and stabilizing BACE1 mRNA
via a 104-nt region of perfect complementarity to exon 6 of the
BACE1 mRNA. By inducing BACE1 expression, overexpression
of BACE1-AS drives AB-42 production in APP mutant HEK-SW
cells (Faghihi et al., 2008). Interestingly, BACE1-AS expression
is itself induced by elevated AB-42 peptide levels. Together
these observations suggest a positive feedback loop, in which
BACE1-AS drives overproduction of toxic AB-42 peptides,
which then feedback to further induce BACE1-AS overexpres-
sion, accelerating amyloid accumulation (Faghihi et al., 2008).
Consistent with this, BACE1-AS is expressed at 2- to 6-foldhigher levels in AD patient brains relative to controls. Further-
more, perfusion of BACE1-AS targeting small interfering RNAs (-
siRNAs) into mice brains reduced both BACE1-AS and BACE1
expression (Faghihi et al., 2008). Reduction of BACE1 expres-
sion has independently been shown to ameliorate disease symp-
toms in animal models of AD (Singer et al., 2005), making this last
result potentially therapeutically relevant. It remains to be seen
whether this translates into the human disease context.
The lncRNA BC1/200 also has been associated with AD dis-
ease progression (Mus et al., 2007). Although BC1/200 expres-
sion declines by >60% during normal aging, it was found to be
significantly upregulated by up to 2.5-fold specifically in AD-
affected brains, in regions including Brodmann area 9 and
the hippocampus, relative to healthy age-matched controls.
The magnitude of BC1/200 overexpression also correlated
strongly with the clinical dementia score in AD patient brains,
and abnormal expression localization (non-somatodendritic)
was observed in advanced AD brains. Although it is not yet clear
whether these expression changes represent a cause or conse-
quence of AD progression, these observations suggest another
interesting candidate lncRNA for further exploration in AD
research.
Neuropathic Pain
KCNA2-ASwas introduced in the previous section on lncRNAs in
neuronal plasticity.We refer the reader to that section for detailed
mechanistic discussion of this lncRNA, but mention it again here
for its role in neuropathic pain. Briefly, KCNA2-AS is induced in
theDRGof rats in response to peripheral nerve injury. Specific in-
duction of KCNA2-AS negatively regulates potassium channel
subunit KCNA2 expression. Remarkably, forced overexpression
of KCNA2-AS is sufficient to generate symptoms of neuropathic
pain. Moreover, blocking KCNA2-AS expression with siRNAs at-
tenuates the development of neuropathic pain following periph-
eral nerve injury, such as spinal nerve ligation or sciatic nerve ax-
otomy (Zhao et al., 2013). Thus, KCNA2-AS appears to be a key
driver of neuropathic pain symptoms and a potential therapeutic
target to prevent human neuropathic pain.
Disease Mechanisms Outlook
All four disease-associated lncRNAs discussed in this section
share a mechanism of action that hinges on close collaboration
with specific protein partners. MSNP1AS regulates levels of
MSN protein;GOMAFU regulates the activity of splicing proteins
QKI, SRSF1, and SF1; BACE1-AS regulates beta-secretase
expression; and KCNA2-AS regulates expression of the potas-
sium channel KCNA2. In cases such as QKI and BACE1, muta-
tion of these interacting proteins also is associated with the
same disease state, potentially via disruption of the same
pathway. However, the fact that GOMAFU and MSNP1AS map
to independent GWAS risk loci suggests that they can play
driving roles in disease progression. Awareness of lncRNA regu-
latory mechanisms may thus offer useful therapeutic targets,
especially since in vivo manipulation of lncRNA expression is
becoming possible (Meng et al., 2015; Modarresi et al., 2012).
Proof of this concept will necessarily await clinical trials. None-
theless, the outlook is optimistic, and continued attention to
the many hundreds of other lncRNAs with either GWAS or tran-
scriptional ties to neurological or psychiatric disorders will likely
uncover additional interesting disease mechanisms.Neuron 88, December 2, 2015 ª2015 Elsevier Inc. 869
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Comparative Genomics Finds a Lack of Evidence for
Protein-Driven Human Brain Evolution
The genetic innovations responsible for phenotypic adaptation
can be studied by comparing the genome sequences of related
species. For example, the FOXP2 transcription factor, which is
required for normal development of speech and language in hu-
mans (Lai et al., 2001), experienced a very strong selective
sweep shortly after the appearance of the Homo sapiens (rapid
positive selection for specific amino acid substitutions relative
to non-human primates, followed by strong purifying selection
in human populations), suggesting a role in the evolution of hu-
man speech and language (Enard et al., 2002). ASPM and
MCPH1 both also show signatures of positive selection in the hu-
man lineage, are expressed in dividing neural precursors, and
cause microcephaly through loss of outer cortical layers when
mutated, suggesting a role in human cortical expansion (Evans
et al., 2004). AHI1 is involved in regulating axon pathfinding
from the cortex to spinal cord and also experienced positive se-
lection in the human lineage, suggesting a role in regulating hu-
man-specific neural connectivity (Ferland et al., 2004).
However, in contrast to these few specific examples of innova-
tions in proteins that are associated with human-specific brain
traits, the vast majority of nervous system proteins are in fact
nearly perfectly conserved across diverse mammalian phyla
(Chimpanzee Sequencing and Analysis Consortium, 2005; Lind-
blad-Toh et al., 2011; Waterston et al., 2002). Moreover, system-
atic surveys of positive selection have uncovered a surprising
lack of enrichment for accelerated amino acid sequence
changes (that imply advantageous variation) in protein-coding
genes related to nervous system function in the human lineage
relative to primates and rodents (Shi et al., 2006; Wang et al.,
2007).
To reconcile this constancy with the obvious and dramatic
changes in human brain anatomy and function relative to other
mammalian species, it is common to appeal to elaboration of
the combinatorial regulatory interactions, which control the
spatiotemporal expression of nervous system genes during
development, as a causal explanation of human brain adapta-
tions (Levine and Tjian, 2003; Prud’homme et al., 2007). Indeed,
accumulating evidence of significant changes in brain-region-
specific gene expression across mammalian species implies
that regulatory changes are widespread and likely to contribute
to phenotypic novelty (reviewed in Somel et al., 2013). Another
common explanation of this paradoxical result is that positive se-
lection only needed to act on a small subset of nervous system
protein-coding genes, which were themselves sufficient to
orchestrate human brain adaptations, while themajority of genes
remained under intense negative selection due to their important
and highly constrained functional roles (Hill and Walsh, 2005).
Comparative Genomics Implicates lncRNAs in Human
Brain Evolution
Independent of protein-driven evolution, there is another attrac-
tive and complementary possibility: human brain adaptations
were driven by changes in non-protein-coding classes of genes,
such as lncRNAs. In support of this and in stark contrast to the
highly conserved repertoire of protein-coding genes, recent
comparative genomic analyses of mammalian lncRNAs have870 Neuron 88, December 2, 2015 ª2015 Elsevier Inc.found that one-third of human lncRNAs appears to be specific
to the primate lineage (Derrien et al., 2012), including hundreds
of human-specific lncRNAs (Tay et al., 2009). Many lncRNA
loci also have experienced positive sequence selection during
human evolution. To date, hundreds to thousands of lncRNA
loci that are positively selected relative to other mammalian spe-
cies (Lindblad-Toh et al., 2011), and 48 lncRNA loci that are posi-
tively selected within specific human populations (Grossman
et al., 2013), have been identified. Hundreds of these are inde-
pendent of any protein-coding gene.
An interesting example of a positively selected lncRNA is
HARF1, which is expressedmost highly in Cajal-Retzius neurons
during gestational weeks 7–19 of human neocortical develop-
ment, a critical period of neuronal specification and migration,
thus consistent with a new functional role in driving human-spe-
cific cortical development (Pollard et al., 2006). Another inter-
esting property of HARF1 is that the positively selected regions
of its locus are in fact highly conserved in other mammals, which
might indicate that they indeed occur in a functional domain of
the lncRNA to drive adaption. Overall the vast scale of this novel
genetic information uniquely available to the developing human
nervous system is difficult to ignore as a potential driver of hu-
man brain adaptations (Barry, 2014; Mattick, 2001, 2003,
2004). It motivates us to consider why we might see such a pre-
ponderance of genomic innovation in lncRNA genes relative to
protein-coding genes, and how this might relate to the emer-
gence of human-specific brain traits.
HowNovel lncRNAs Could Contribute to Human-Specific
Brain Traits
Increasing Cortical Size and Cellular Diversity. The human brain
is approximately three times larger than the chimpanzee brain,
from which we diverged 7–8 million years ago, and about twice
the size of pre-human hominids that lived approximately 2.5
million years ago (Carroll, 2003). The most dramatically
expanded human brain region is the cortex, which serves as
the seat of our higher cognitive functions. Relative to lower mam-
mals, the human cortex contains higher overall cell numbers, a
relative abundance of cortical interneurons, and some entirely
new cell types, such as spindle cells, precocious predecessor
cells, and fusiform cells. The human brain also has: higher neuro-
pil density; certain cortical regions that are not present in lower
mammals, such as language centers; and a higher degree of
asymmetry between hemispheres (reviewed in Carroll, 2003;
Kaas, 2013).
Thousands of new lncRNAs have appeared during primate
nervous system evolution, where they are expressed in a highly
region-specific manner, consistent with a role in the spatiotem-
poral regulation of cellular identity. In fact, lncRNAs serve as
better markers for subpopulations of upper cortical neurons
than protein-coding genes (Molyneaux et al., 2015). They can,
moreover, directly regulate cell-fate choice in the developing
brain through mechanisms analogous to those seen for EVF2,
SIX3OS, and DLX1AS (see above), and they can drive cellular
identity changes when expressed ectopically (Gupta et al.,
2010; Loewer et al., 2010; Rinn et al., 2007). LncRNA genes
are, therefore, in principle, ideal genetic substrates to have
driven brain expansion and cellular diversification during human
evolution. To gain direct evidence of this evolutionary function,
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man-specific lncRNAs to ancestrally related mammalian brains
or look for human brain diseases associated with mutations in
human-specific lncRNAs.
Enhancing Learning through New Regulation of Neural Plas-
ticity. The extent of synaptic interconnectivity, the organization
of particular inter- and intra-regional circuit architectures, and
the synaptic learning rules governing how specific circuits are
formed, lost, strengthened, or weakened are all known to influ-
ence the computational properties of the brain (Gardner, 1993).
Human cognitive prowess may therefore be related to enhance-
ment of these processes, though this idea awaits empirical sup-
port. LncRNAs directly modulate the duration and extent of syn-
aptogenesis during development and mature neural function,
opening opportunities for new lncRNAs to influence human-spe-
cific circuit architectures. They are also integrated into activity-
dependent regulatory circuits, where they dynamically control
transcriptional, post-transcriptional, and translational changes,
and, therefore, could refine human-specific regulation of neural
plasticity. Primate-specific lncRNAs such as BDNF-AS (Lipovich
et al., 2012), which is activity dependent and regulates dendritic
arborization (see above), could be interesting subjects for future
evolutionary studies.
Scaffolding Molecular Interactions to Improve Inter-neuronal
Communication.Control of signal-to-noise ratios is a major chal-
lenge associated with the expansion of highly interconnected
neural networks that, if left unchecked, can offset any advantage
in the power of growing a larger brain (Koch, 2004; Laughlin and
Sejnowski, 2003). Certain molecular mechanisms have evolved
that help combat these issues, such as the proteins HOMER
and SHANK, which regulate interactions between signaling mol-
ecules within synapses to improve the fidelity of neuronal signal
transmission (Shcheglovitov et al., 2013). The scaffold-like prop-
erties of lncRNAs make them ideal for analogous roles in modu-
lating the biophysical properties of communicating neurons. One
known example of a scaffold-like lncRNA that acts at synapses
to influence inter-neuronal connectivity is the BC1/BC200
lncRNA, which as noted above regulates stimulus-dependent
translation of key plasticity-related genes and is required for
normal brain function in mice (Centonze et al., 2007; Zalfa
et al., 2003; Zhong et al., 2009). Other similar examples may
be uncovered by future studies.
Acting as New Signaling Molecules at Synapses. Another way
to enhance the computational power of a neural network, of
given size, is to allow for increasing numbers of independent
messages with distinct meaning. Our brains are far more power-
ful for having multiple classes of neurotransmitters, such as
glutamate, serotonin, dopamine, etc., than had they only utilized
one such class of signal (Gardner, 1993). Intercellular communi-
cation through vesicle-mediated transport of lncRNAs, small
ncRNAs, and mRNAs is increasingly being identified as an
important physiological and developmental regulatory mecha-
nism (Dinger et al., 2008; Fru¨hbeis et al., 2012; van der Vos
et al., 2011). Such mechanisms are known to operate between
cells of the nervous system, but the functional consequences
of this mechanism remain poorly understood. However, by
transmitting lncRNAs across synapses, it would in principle be
possible to tune local post-synaptic properties, for example,by regulating post-synaptic translation of specific mRNAs via
lncRNAs such as BC1/200, or to regulate the global transcrip-
tional state of the post-synaptic neuron by lncRNAs that regulate
transcription. If evolution has accessed this communication
paradigm, lncRNAs may therefore have contributed to the
evolution of human cognition by enriching information encoded
in neural communication.
Why Might Evolution Have Extensively Employed
lncRNAs as an Adaptive Genetic Substrate?
Modularity is an organizational property that is characteristic of
evolvable living systems (Gerhart and Kirschner, 2007; Kirschner
and Gerhart, 1998). Theoretical work has shown that modularity
of functional RNA molecules arises spontaneously from environ-
mental canalization under constant selective pressures (Ancel
and Fontana, 2000). Indeed, metazoan lncRNAs are composed
of modular functional domains, which each possess unique
sets of DNA, RNA, or protein-binding partners, that form regula-
tory linkages between pre-existing genetic and biochemical
pathways (Box 1). TERC is a good example of such an lncRNA,
and it ranges from 200 bp to 5 kb in size depending on the set of
modules spliced into the mature lncRNA from the multiexon
gene locus (Lingner et al., 1997).
The modular organization of lncRNAs is highly evolvable for at
least three reasons. First, it allows each domain to explore new
functional properties, such as new or altered binding partners,
somewhat independently of the other functional domains. This
is different to the case of proteins, where the overall structure
and function of the protein macromolecule often depends
more heavily on a large number of the constituent residues. Sec-
ond, it allows parts of the lncRNA gene body that do not already
contain functional domains to freely explore sequence space
and potentially evolve new domains. There may be some selec-
tive pressures on maintaining particular secondary structures,
but this is dramatically lower than in protein-coding genes, as
evidenced by the much lower sequence conservation in lncRNA
gene bodies relative to coding sequences. Finally, it allows new
combinations of modules to be generated readily by transposi-
tion or recombination events (Johnson and Guigo´, 2014; Kelley
and Rinn, 2012).
Here we suggest that the evolvable nature of lncRNA mole-
cules helps to explain why lncRNA genes appeared and then
rapidly expanded in modern metazoan species, and it further-
more supports a role for lncRNAs in driving the adaptive pro-
cesses underlying human brain evolution.
Conclusions
The initial discovery of tens of thousands of lncRNAs that show
exquisitely spatiotemporally specific expression patterns in the
mammalian brain raises the obvious prospect that they are bio-
logically meaningful and begs the question as to what their func-
tional roles (if any) may be. Here we have reviewed emerging
studies that have begun to address this question and uncovered
essential roles for lncRNAs in the development, plasticity,
and disease of mammalian nervous systems. The basic and
biomedical implications of these findings, especially with many
thousands of other lncRNA transcripts that remain poorly under-
stood, are abundantly clear. We have further synthesized these
results within a comparative genomics framework to argue thatNeuron 88, December 2, 2015 ª2015 Elsevier Inc. 871
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ated driver of human brain adaptations responsible for the evo-
lution of human cognition (Koziol and Rinn, 2010; Mattick et al.,
2009; Mercer and Mattick, 2013). We hope that other re-
searchers share our enthusiasm moving forward, and consider
the potential underlying roles of lncRNAs in their neural system
of study. Looking further forward, we anticipate that expanding
field of lncRNA research in the nervous system will merge with
the emerging field of epitranscriptomics (Saletore et al., 2012),
as the molecular basis of the plasticity of the nervous system ap-
pears to be intimately linked to the expansion of RNA editing and
RNAmodification, which have expanded during cognitive evolu-
tion, as well as DNA remodeling (by reverse transcriptase-linked
DNA repair) and retrotransposon mobilization, which both occur
in the human brain (Baillie et al., 2011; Cantara et al., 2011; Mat-
tick, 2010; Mattick and Mehler, 2008; Saletore et al., 2012).AUTHOR CONTRIBUTIONS
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